Literature DB >> 18560740

[DPOAE and lateral inhibition in chronic tinnitus].

G Hesse1, R Andres, H Schaaf, A Laubert.   

Abstract

INTRODUCTION: According to our audiological data, 90% of tinnitus patients have deficits in inner ear function as a generator of tinnitus, mainly in the outer hair cells (OHC). This can be verified by registration of distortion products of otoacoustic emissions (DPOAE). Thus, the main origin of tinnitus is peripheral, and most patients suffer from accompanying hearing loss, even though it is sometimes mild or subjectively not even felt. Whether or not the tinnitus is disturbing, however, is determined through further auditory processing of the "signal" tinnitus and its psychological validation. With almost 50% of our tinnitus and hyperacusis patients, we find hyperfunctioning of the OHC, possibly originating from reduced or ineffective efferent control in the auditory pathway. Efferent activity can be measured by acoustic stimulation of the contralateral ear, which normally reduces the DPOAE amplitudes via efferent inhibition. METHOD AND PATIENTS: DPOAE were recorded with 67 tinnitus patients (127 ears) with and without contralateral acoustic stimulation. Twenty-one persons (41 ears) served as controls.
RESULTS: With 64% of the tinnitus patients, DPOAE amplitudes were not reduced significantly, compared with 34% of the controls. The medium amplitude reduction for controls was 1.76 dB, whereas for the tinnitus patients it was significantly less (0.91 dB).
CONCLUSION: For a considerable number of tinnitus patients, efferent control of OHC activity is restricted, but this seems to be confined to a certain type of tinnitus only.

Entities:  

Mesh:

Year:  2008        PMID: 18560740     DOI: 10.1007/s00106-008-1730-1

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  25 in total

Review 1.  Mismatch negativity: clinical and other applications.

Authors:  R Näätänen; C Escera
Journal:  Audiol Neurootol       Date:  2000 May-Aug       Impact factor: 1.854

2.  GIN (Gaps-In-Noise) test performance in subjects with confirmed central auditory nervous system involvement.

Authors:  Frank E Musiek; Jennifer B Shinn; Robert Jirsa; Doris-Eva Bamiou; Jane A Baran; Elena Zaida
Journal:  Ear Hear       Date:  2005-12       Impact factor: 3.570

3.  Central projections of auditory-nerve fibers of differing spontaneous rate. I. Anteroventral cochlear nucleus.

Authors:  M C Liberman
Journal:  J Comp Neurol       Date:  1991-11-08       Impact factor: 3.215

4.  Salicylate and quinine selectively increase spontaneous firing rates in secondary auditory cortex.

Authors:  J J Eggermont; M Kenmochi
Journal:  Hear Res       Date:  1998-03       Impact factor: 3.208

5.  Tinnitus remission objectified by neuromagnetic measurements.

Authors:  C Pantev; M Hoke; B Lütkenhöner; K Lehnertz; W Kumpf
Journal:  Hear Res       Date:  1989-07       Impact factor: 3.208

6.  Focal metabolic activation in the predominant left auditory cortex in patients suffering from tinnitus: a PET study with [18F]deoxyglucose.

Authors:  W Arnold; P Bartenstein; E Oestreicher; W Römer; M Schwaiger
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1996 Jul-Aug       Impact factor: 1.538

7.  [Effect of contralateral noise exposure on otoacoustic distortion product emissions in man].

Authors:  B Richter; R Hauser; E Löhle
Journal:  Laryngorhinootologie       Date:  1995-03       Impact factor: 1.057

8.  Neurophysiological model of tinnitus: dependence of the minimal masking level on treatment outcome.

Authors:  P J Jastreboff; J W Hazell; R L Graham
Journal:  Hear Res       Date:  1994-11       Impact factor: 3.208

9.  Contralateral suppression of transiently evoked otoacoustic emissions and tinnitus.

Authors:  S Chéry-Croze; E Truy; A Morgon
Journal:  Br J Audiol       Date:  1994 Aug-Oct

10.  Medial olivo-cochlear system and tinnitus.

Authors:  S Chéry-Croze; L Collet; A Morgon
Journal:  Acta Otolaryngol       Date:  1993-05       Impact factor: 1.494

View more
  5 in total

Review 1.  [High-resolution distortion-product otoacoustic emissions: method and clinical applications].

Authors:  T Janssen; A Lodwig; J Müller; H Oswald
Journal:  HNO       Date:  2014-10       Impact factor: 1.284

Review 2.  [Pharmacotherapy of acute and chronic hearing loss].

Authors:  G Hesse; A Laubert
Journal:  HNO       Date:  2010-10       Impact factor: 1.284

3.  [Hearing aids, implantable hearing aids and cochlear implants in chronic tinnitus therapy].

Authors:  H Olze; T Zahnert; G Hesse
Journal:  HNO       Date:  2010-10       Impact factor: 1.284

4.  Increased contralateral suppression of otoacoustic emissions indicates a hyperresponsive medial olivocochlear system in humans with tinnitus and hyperacusis.

Authors:  Inge M Knudson; Christopher A Shera; Jennifer R Melcher
Journal:  J Neurophysiol       Date:  2014-09-17       Impact factor: 2.714

5.  Evaluation of distortion and transient evoked otoacoustic emission in tinnitus patients with normal hearing.

Authors:  Helnaz Mokrian; Abdolreza Shaibanizadeh; Saeid Farahani; Shohreh Jalaie; Parvane Mahdi; Amin Amali; Homa Arian Nahad
Journal:  Iran J Otorhinolaryngol       Date:  2014-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.